| For general practitioner doctors, deciding which patients to send for follow-up brain imaging can be extremely difficult. This is partly because brain tumors may for long time - perhaps even several years - only cause vague symptoms such as headaches or dizziness. By the time they are diagnosed, it could be too late to treat some patients. The new infrared spectroscopy blood serum test developed by the Strathclyde team promises much more effective triage, meaning that those with a blood biosignature indicating the likely presence of cancer can be sent for urgent scans and earlier diagnosis. Image: University of Strathclyde. |
